Shockwave Medical, Inc. (NASDAQ: SWAV) to acquire Neovasc Inc. (NASDAQ/TSX: NVCN) for US $27.25 per share for US $100M upfront in cash, plus up to US $12 per share in deferred payment for up to US $47M. Continue Reading
Akshay Nanduri and Salmaan Ahmed’s Onc.AI has raised US $25M in Series A funding led by MassMutual and Action Potential Venture Capital (a GSK venture fund) with participation of Life Extension Ventures, Blue Venture Fund, Accomplice, Digitalis Ventures, and KdT Ventures. Continue Reading
Fonds de solidarité FTQ and Crédit Mutuel Equity backed Searchlight Pharma to acquire Nuvo Pharmaceuticals Inc. dba Miravo Healthcare for $91.4M from Deerfield Management Company, Red Oak Partners, LLC, and other shareholders.Continue Reading
Dr. Christian Dansereau and César Laurent’s Perceiv AI secured $1.M in seed funding led by Plug & Play Ventures with participation of Centre for Aging + Brain Health Innovation (CABHI), Boreal Ventures, IKJ Capital, Red Abbey Labs, Investissement Québec, private investors. Continue Reading
ABK Biomedical secured US $30M Series C led by Santé Ventures and Medtronic with participation of existing investors F-Prime Capital, Eight Roads Ventures and others. Carissa Bellardine Black from Medtronic and James Eadie from Santé Ventures joined ABK board of directors. Continue Reading
Andrew Arruda, Thomas Hamilton, and Joshua Kelly founded Automate Medical secured seed financing with Apollo Projects, Tribe Capital, Village Global, and Canadian and US private investors.
Continue Reading
Q BioMed Inc. converted its long-term royalty agreement with Mannin Research Inc., receiving 15% stakes, at CDN $30M valuation, and US $20M in royalty payment on realization of future net sales.Continue Reading
KA Imaging secured funding from INOVAIT through Government of Canada’s Strategic Innovation Fund, and strategic investment and technology development agreement with In-Q-Tel. Continue Reading
Marinus Pharmaceuticals entered into a revenue interest financing agreement with Sagard Healthcare Partners for US $32.5M upfront in return for payments based on U.S. net sales of ganaxolone, including the recently approved ZTALMY® (ganaxolone) oral suspension CV. Continue Reading
enGene secured new round of bridge financing led by Forbion Capital Partners with participation of Fonds de solidarité FTQ and Lumira funds.Continue Reading
Monteris Medical secured US $35M Series D led by InnovaHealth Partners with participation of Birchview Capital and US $28M debt facility provided by Madryn Asset Management, LP with option to draw an additional US $10M. Continue Reading
Inversago Pharma secured US $70M Series C led by New Enterprise Associates (NEA) with participation of Forbion Growth Opportunities Fund, Amgen Ventures, and existing investors Forbion Capital Fund IV, Fonds de solidarité FTQ, Genesys Capital, AmorChem, JDRF T1D Fund and adMare BioInnovations. Continue Reading
CSE listed TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) closed non-brokered senior secured term loan for US $45.5M from funds managed by Pelorus Equity Group. Continue Reading
RadioMedix secured US $40M Series A funding from Portland Investment Counsel Inc. Continue Reading
Dusanka Filipovic founded and Kipton Lade led Blue-Zone Technologies secured $8M financing jointly led by Canadian Venture Capital arm of Crédit Mutuel Equity and Round Pound Ventures, LLC. David Bacon, CEO of Halocarbon Life Sciences, joined Blue-Zone board of directors. Continue Reading
SK Capital Partners to acquire Dr. Barry Sherman founded and Jeff Watson and Gordon Fahner led Apotex Pharmaceutical Holdings Inc. RBC Capital Markets, The Bank of Nova Scotia, HSBC and Truist Securities are providing committed debt financing. Continue Reading
Andrew Wilson led GrowerIQ secured $3M seed funding led by Golden Section and MaRS Investment Accelerator Fund (MaRS IAF) with participation from LAGO, Delbridge, GTM Fund and Gaingels.
Continue Reading
